GenoML: Automated Machine Learning for Genomics
Authors:
Mary B. Makarious,
Hampton L. Leonard,
Dan Vitale,
Hirotaka Iwaki,
David Saffo,
Lana Sargent,
Anant Dadu,
Eduardo Salmerón Castaño,
John F. Carter,
Melina Maleknia,
Juan A. Botia,
Cornelis Blauwendraat,
Roy H. Campbell,
Sayed Hadi Hashemi,
Andrew B. Singleton,
Mike A. Nalls,
Faraz Faghri
Abstract:
GenoML is a Python package automating machine learning workflows for genomics (genetics and multi-omics) with an open science philosophy. Genomics data require significant domain expertise to clean, pre-process, harmonize and perform quality control of the data. Furthermore, tuning, validation, and interpretation involve taking into account the biology and possibly the limitations of the underlyin…
▽ More
GenoML is a Python package automating machine learning workflows for genomics (genetics and multi-omics) with an open science philosophy. Genomics data require significant domain expertise to clean, pre-process, harmonize and perform quality control of the data. Furthermore, tuning, validation, and interpretation involve taking into account the biology and possibly the limitations of the underlying data collection, protocols, and technology. GenoML's mission is to bring machine learning for genomics and clinical data to non-experts by develo** an easy-to-use tool that automates the full development, evaluation, and deployment process. Emphasis is put on open science to make workflows easily accessible, replicable, and transferable within the scientific community. Source code and documentation is available at https://genoml.com.
△ Less
Submitted 4 March, 2021;
originally announced March 2021.
Learning the progression and clinical subtypes of Alzheimer's disease from longitudinal clinical data
Authors:
Vipul Satone,
Rachneet Kaur,
Faraz Faghri,
Mike A Nalls,
Andrew B Singleton,
Roy H Campbell
Abstract:
Alzheimer's disease (AD) is a degenerative brain disease impairing a person's ability to perform day to day activities. The clinical manifestations of Alzheimer's disease are characterized by heterogeneity in age, disease span, progression rate, impairment of memory and cognitive abilities. Due to these variabilities, personalized care and treatment planning, as well as patient counseling about th…
▽ More
Alzheimer's disease (AD) is a degenerative brain disease impairing a person's ability to perform day to day activities. The clinical manifestations of Alzheimer's disease are characterized by heterogeneity in age, disease span, progression rate, impairment of memory and cognitive abilities. Due to these variabilities, personalized care and treatment planning, as well as patient counseling about their individual progression is limited. Recent developments in machine learning to detect hidden patterns in complex, multi-dimensional datasets provides significant opportunities to address this critical need. In this work, we use unsupervised and supervised machine learning approaches for subtype identification and prediction. We apply machine learning methods to the extensive clinical observations available at the Alzheimer's Disease Neuroimaging Initiative (ADNI) data set to identify patient subtypes and to predict disease progression. Our analysis depicts the progression space for the Alzheimer's disease into low, moderate and high disease progression zones. The proposed work will enable early detection and characterization of distinct disease subtypes based on clinical heterogeneity. We anticipate that our models will enable patient counseling, clinical trial design, and ultimately individualized clinical care.
△ Less
Submitted 5 December, 2018; v1 submitted 2 December, 2018;
originally announced December 2018.
